Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2023 Annual Meeting | H176 - Quality and Reimbursement: Convergence Over the Last 50 Years (Innovation Hub)

Monday 04/24/23
03:15 PM - 03:45 PM EST Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Hubs (Innovation)
Jeffrey R. Buchhalter, MD, FAAN
Behavioral and Cognitive Neurology, Education, Research, and Methodology, General Neurology, Global Health and Neuroepidemiology
Since the introduction of Medicare and Medicaid in the 1960's, reimbursement for clinical services has become increasingly complex. When the government began funding outpatient and inpatient services, it became apparent that there would need to be some "accountability" in an effort to keep the system solvent. Simultaneously, the field of "evidence-based medicine" came into existence and with it, the desire and methodology to measure the quality of services delivered. In this session, we will explore the intersection of these two important trends as well as the implications for careprover autonomy.
Objectives:
As a result of this presentation, learners will understand:
1. The evolution of government funded reimbursement for healthcare in the USA
2. The development of quality measures & intersection with reimbursement
3. The opportunity for care providers to optimize outcomes and get paid to do it
Participants will learn how CMS has incorporated quality measures into reimbursement for clinical services, how quality methodology was developed and is currently used to improve outcomes, and increase their understanding and apply the reality that clinician reimbursement is partially based in quality reporting.
0.00 CME credit
Practice-based Learning and Improvement, Systems-based Practice, Quality Improvement
Introductory
Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student, Business Administrator
Didactic

Program Materials Program Evaluations

Event Timeline
03:15 PM - 03:45 PM EST Speaker Quality and Reimbursement: Convergence Over the Last 50 Years
Jeffrey R. Buchhalter, MD, FAAN
Faculty Disclosures
Jeffrey R. Buchhalter, MD, FAAN Dr. Buchhalter has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Epilepsy Foundation. Dr. Buchhalter has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Epilepsy Study Consortium. Dr. Buchhalter has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Epilog. Dr. Buchhalter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Buchhalter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shackelford Pharmaceuticals. Dr. Buchhalter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex. Dr. Buchhalter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Buchhalter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biocodex.